| [1] |
Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges[J]. Nat Rev Clin Oncol, 2010, 7(3): 163-172.
|
| [2] |
Seufferlein T, Bachet JB, Van Cutsem E, et al. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2012, 23(7): 33-40.
|
| [3] |
Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer[J]. Postgrad Med J, 2008, 84(995): 478-497.
|
| [4] |
Coffelt SB, Hughes R, Lewis CE. Tumor-associated macrophages: effectors of angiogenesis and tumor progression[J]. Biochim Biophys Acta, 2009, 1796(1): 11-18.
|
| [5] |
李奕，蔡真.肿瘤相关巨噬细胞与肿瘤生长和治疗的研究进展[J]. 中国肿瘤生物治疗杂志, 2011, 18(4): 441-447.
|
| [6] |
Laoui D, Movahedi K, Van Overmeire E, et al. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions[J]. Int J Dev Biol, 2011, 55(7-9): 861-867.
|
| [7] |
Kedra B, Popiela T, Sierzega M, et al. Prognostic factors of longterm survival after resective procedures for pancreatic cancer[J]. Hepatogastroenterology, 2001, 48(42): 1762-1766.
|
| [8] |
Tezel E, Kaneko T, Sugimoto H, et al. Clinical significance of intraportal endovascular ultrasonography for the diagnosis of extrapancreatic nerve plexus invasion by pancreatic carcinoma[J]. Pancreatology, 2004, 4(2): 76-81.
|
| [9] |
Allavena P, Sica A, Solinas G, et al. The inflammatory micro-environment in tumor progression: the role of tumor-associated macr- ophages[J]. Crit Rev Oncol Hematol, 2008, 66(1): 1-9.
|
| [10] |
Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis[J]. Nat Rev Cancer, 2004, 4(1): 71-78.
|
| [11] |
Su S, Liu Q, Chen J, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis[J]. Cancer Cell, 2014, 25(5): 605-620.
|
| [12] |
Ioannides CG, Whiteside TL. T cell recognition of human tumors:implications for molecular immunotherapy of cancer[J]. Clin Immunol Immunopathol, 1993, 66(2): 91-106.
|
| [13] |
Liou GY, Doppler H, Necela B, et al. Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions[J]. Cancer Discov, 2015, 5(1): 52-63.
|
| [14] |
李康，郭强，王翠妮,等. M1和M2型巨噬细胞表型的比较分析[J].现代免疫学, 2008, 28(3): 177-183.
|
| [15] |
Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance[J]. Front Immunol, 2014, 5(2): 614-615.
|
| [16] |
曹春雨，王清，王艳林.肿瘤相关巨噬细胞极化的研究进展[J].生命科学, 2013, 25(11): 1105-1108.
|
| [17] |
Lawrence T. Macrophages and NF-kappaB in cancer[J]. Curr Top Microbiol Immunol, 2011, 349(3): 171-184.
|
| [18] |
Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes[J]. Trends Immunol, 2002, 23(11): 549-555.
|
| [19] |
李晓曦，郭宁，曹雪涛.肿瘤相关巨噬细胞促进肿瘤生长与转移的研究现状[J].中国肿瘤生物治疗杂志, 2008, 15(1): 78-81.
|
| [20] |
Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anti-cancer therapies[J]. J Pathol, 2002, 196(3): 254-265.
|
| [21] |
耿晓强. M2型肿瘤相关巨噬细胞在肿瘤中作用的研究进展及肿瘤治疗的新思路[J].中国实用内科杂志, 2014, 34(1): 169-171.
|
| [22] |
Chen J. Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases[J]. Adv Cancer Res, 2012, 114(2): 1-20.
|
| [23] |
Saglam O, Garrett CR, Boulware D, et al. Activation of the serine/threonine protein kinase AKT during the progression of colorectal neoplasia[J]. Clin Colorectal Cancer, 2007, 6(9): 652-656.
|
| [24] |
Schlieman MG, Fahy BN, Ramsamooj R, et al. Incidence, mechanism and prognostic value of activated AKT in pancreas cancer[J]. Br J Cancer, 2003, 89(11): 2110-2115.
|
| [25] |
Asano T, Yao Y, Zhu J, et al. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells[J]. Oncogene, 2004, 23(53): 8571-8580.
|
| [26] |
Stephan S, Datta K, Wang E, et al. Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer[J]. Clin Cancer Res, 2004, 10(20): 6993-7000.
|